コラーゲン・ゼラチン市場:供給源別(牛、豚、海産物)、用途別(創傷治療、整形外科、心臓血管、歯科、外科、神経修復)、エンドユーザー別(病院、外科センター)、地域別 - 2028年までの世界予測Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopaedic, Cardiovascular, Dental, Surgical, Nerve Repair), End User (Hospitals, Surgical Centers), Region - Global Forecast to 2028 世界のコラーゲン・ゼラチン市場規模は、2023年の12億米ドルから2028年には16億米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。コラーゲンとゼラチンの創傷治療用途への採用の増加や、コラー... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー世界のコラーゲン・ゼラチン市場規模は、2023年の12億米ドルから2028年には16億米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。コラーゲンとゼラチンの創傷治療用途への採用の増加や、コラーゲンとゼラチンの研究への資金提供の増加などの要因が、市場の成長を促進している。心臓血管手術の増加も市場成長にプラスの影響を与えそうだ。"コラーゲン・ゼラチン市場において、予測期間中、供給源別ではウシセグメントが圧倒的なシェアを占めた。" 供給源に基づき、世界のコラーゲン・ゼラチン市場はウシ、ブタ、その他の供給源に区分される。豚由来セグメントは2022年に最大のシェアを占めた。これは主に、組織工学におけるその高い広範な使用と創傷治療用途の生体材料の需要増加によるものである。生体適合性、構造的支持、保湿性など様々な要因により、様々な創傷治療用途で牛由来コラーゲン製品の使用が増加している。 "整形外科セグメントは、2022年にアプリケーションセグメントで最大のシェアを占めた。" 用途別では、世界のコラーゲン市場は、創傷ケア、歯科、整形外科、外科、心臓血管に区分される。ゼラチンの世界市場は、整形外科、創傷治療、その他の用途に区分される。2022年のコラーゲン・ゼラチン市場で最大のシェアを占めたのは整形外科分野であった。このセグメントの優位性は、様々な整形外科手術におけるゼラチンおよびコラーゲンベースの製品の使用の増加、および足場に対する需要の増加に起因する。 "アジア太平洋地域はより速いペースで成長する可能性が高い" コラーゲン・ゼラチン市場は、北米、アジア太平洋、ヨーロッパ、その他の地域に区分される。アジア太平洋地域は大きなCAGRで成長すると予想されている。この地域の成長は、慢性創傷の有病率の増加と慢性潰瘍に苦しむ人々の数が主な要因である。さらに、コラーゲンベースの創傷ケア製品の需要増加や手術件数の増加が、同地域の成長を加速させる可能性が高い。 本レポートのために実施した一次インタビューは以下のように分類できる: - 回答者別供給側70%、需要側30 - 回答者の役職別(供給側):マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25 - 地域別北米:40%、欧州:25%、アジア太平洋地域:20%、中南米:10%、中東・アフリカ:5 レポート掲載企業リスト - インテグラ・ライフサイエンシズ(米国) - DSM(オランダ) - コルプラント・バイオテクノロジーズ社(イスラエル(イスラエル) - 新田ゼラチン(日本) - コラーゲンソリューションズ英国 - コラーゲンマトリックス社(米国) - シマテーゼ(フランス) - ゲリータAG(ドイツ) - Tessenderlo Group ( BU PB Leiner ) (ベルギー) - スミス・アンド・ネフュー(英国) - ジムヴィ(米国) - ジェラーゲン(英国) - アドバンスト・バイオマトリックス(米) - マトリセルGmbH(ドイツ) - ルーセロット(オランダ) - ワイシャールト(フランス) - 廈門ハイファインゼラチン(中国) - ガイストリッヒ製薬(スイス) - シナヒール・ファーマシューティカルズ(インド) - バイオリジェンテクノロジーズ(インド) - メリルライフサイエンス(インド) - メドスキン・スーベラック(ドイツ) - Cologenesis Healthcare Pvt Ltd(インド) - ダーマライト・インダストリーズLLC(米国) - ユーケア・ファーマシューティカルズ・プライベート・リミテッド(インド) 調査範囲 この調査レポートは、コラーゲンとゼラチン市場の詳細な情報を提供しています。製品、用途、エンドユーザー、地域などの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。 レポート購入の主な利点 本レポートは、コラーゲン・ゼラチン市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。 本レポートは、以下のポイントに関する洞察を提供します: - コラーゲン・ゼラチン市場の成長に影響を与える主な促進要因(糖尿病、癌、慢性創傷の罹患率の増加、研究開発への資金・投資の増加、外科手術数の増加)、阻害要因(代替生体材料の入手可能性)、機会(21世紀治療法の実施)、課題(不十分な加工技術)の分析。 - 製品開発/イノベーション:コラーゲン・ゼラチン市場の新発売製品に関する詳細な洞察。 - 市場開発:有利な市場に関する包括的情報 - 当レポートでは、様々な地域のコラーゲン・ゼラチン市場を分析しています。 - 市場の多様化:コラーゲン・ゼラチン市場における新サービス、未開拓の地域、最近の開発、投資に関する詳細な情報。 - 競合評価:主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。Integra LifeSciences社(米国)、DSM社(オランダ)、CollPlant Biotechnologies Ltd.(イスラエル)、新田ゼラチン株式会社(日本)、コラーゲン・ソリューションズ社(英国)(英国)などがコラーゲン・ゼラチン市場に参入している。 目次1 INTRODUCTION 291.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.2.1 INCLUSIONS AND EXCLUSIONS 29 1.3 MARKET SCOPE 30 1.3.1 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 31 1.5 LIMITATIONS 31 1.6 STAKEHOLDERS 31 1.7 SUMMARY OF CHANGES 31 1.7.1 RECESSION IMPACT 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 FIGURE 1 COLLAGEN AND GELATIN MARKET: RESEARCH DESIGN 33 2.1.1 SECONDARY DATA 34 2.1.2 PRIMARY DATA 35 FIGURE 2 COLLAGEN AND GELATIN MARKET: BREAKDOWN OF PRIMARIES 35 2.2 MARKET SIZE ESTIMATION 36 FIGURE 3 COLLAGEN AND GELATIN MARKET SIZE ESTIMATION, 2022 36 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 37 FIGURE 5 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES: REVENUE SHARE ANALYSIS, 2022 37 2.2.1 INSIGHTS FROM PRIMARIES 39 FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 39 2.2.2 SEGMENTAL ASSESSMENT (BY SOURCE, APPLICATION, AND END USER): TOP-DOWN APPROACH 39 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 39 2.3 GROWTH RATE ASSUMPTIONS 40 FIGURE 8 COLLAGEN AND GELATIN MARKET: CAGR PROJECTIONS, 2023–2028 41 FIGURE 9 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 41 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 42 FIGURE 10 DATA TRIANGULATION METHODOLOGY 42 2.5 STUDY ASSUMPTIONS 43 2.6 RISK ANALYSIS 43 2.7 IMPACT OF RECESSION ON COLLAGEN AND GELATIN MARKET 43 TABLE 1 GLOBAL INFLATION RATE, 2021–2028 (%) 44 TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 44 TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 44 3 EXECUTIVE SUMMARY 45 FIGURE 11 COLLAGEN AND GELATIN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 45 FIGURE 12 COLLAGEN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 13 GELATIN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 14 COLLAGEN AND GELATIN MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47 FIGURE 15 REGIONAL SNAPSHOT OF COLLAGEN AND GELATIN MARKET 48 4 PREMIUM INSIGHTS 49 4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 49 FIGURE 16 INCREASED PREVALENCE OF DIABETES AND CANCER TO DRIVE MARKET 49 4.2 COLLAGEN AND GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2022 50 FIGURE 17 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN AND GELATIN MARKET, BY SOURCE AND COUNTRY, RESPECTIVELY, IN 2022 50 4.3 COLLAGEN AND GELATIN MARKET SHARE, BY SOURCE, 2023 VS. 2028 51 FIGURE 18 BOVINE SEGMENT TO DOMINATE MARKET IN 2028 51 4.4 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2022 51 FIGURE 19 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2022 51 4.5 COLLAGEN AND GELATIN MARKET GROWTH OPPORTUNITIES, BY COUNTRY, 2023–2028 52 FIGURE 20 JAPAN TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2023 TO 2028 52 FIGURE 21 CHINA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET DURING FORECAST PERIOD 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 TABLE 4 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS 55 5.2.1 DRIVERS 55 5.2.1.1 Increasing prevalence of diabetes & chronic wounds and cancer 55 5.2.1.2 Rising investments and funding in R&D of collagen and gelatin products 56 5.2.1.3 Growing number of surgical procedures 56 TABLE 5 NUMBER OF SURGERIES PERFORMED IN US, 2022–2023 57 5.2.2 RESTRAINTS 57 5.2.2.1 Availability of alternative biomaterials to collagen and gelatin 57 5.2.3 OPPORTUNITIES 58 5.2.3.1 Enforcement of 21st Century Cures Act 58 5.2.4 CHALLENGES 58 5.2.4.1 Lack of advanced manufacturing and marketing technologies 58 5.3 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 59 FIGURE 23 INCREASED USE OF COLLAGEN AND GELATIN PRODUCTS IN WOUND CARE AND SURGICAL PROCEDURES IS LIKELY TO HAVE POSITIVE IMPACT ON THE GROWTH OF THE MARKET 59 5.4 VALUE CHAIN ANALYSIS 59 FIGURE 24 COLLAGEN AND GELATIN MARKET: VALUE CHAIN ANALYSIS 60 5.5 SUPPLY CHAIN 60 FIGURE 25 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET 61 5.6 COLLAGEN AND GELATIN MARKET: ECOSYSTEM ANALYSIS 62 5.7 TECHNOLOGY ANALYSIS 62 5.8 PORTER’S FIVE FORCES ANALYSIS 63 TABLE 6 COLLAGEN AND GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS 63 5.8.1 THREAT OF NEW ENTRANTS 63 5.8.2 THREAT OF SUBSTITUTES 63 5.8.3 BARGAINING POWER OF SUPPLIERS 63 5.8.4 BARGAINING POWER OF BUYERS 64 5.8.5 INTENSITY OF COMPETITIVE RIVALRY 64 5.9 REGULATORY ANALYSIS 64 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 5.10 PATENT ANALYSIS 67 FIGURE 26 PATENTS GRANTED FOR COLLAGEN MARKET, JUNE 2013–JUNE 2023 67 5.10.1 LIST OF MAJOR PATENTS 67 FIGURE 27 PATENTS GRANTED FOR GELATIN MARKET, JUNE 2013–JUNE 2023 69 5.11 KEY CONFERENCES AND EVENTS, 2023–2024 70 TABLE 12 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 70 5.12 PRICING ANALYSIS 70 5.12.1 AVERAGE SELLING PRICE TREND ANALYSIS 70 TABLE 13 GELATIN MARKET: AVERAGE SELLING PRICE, BY SOURCE AND REGION, 2022–2023 (USD/KG) 71 TABLE 14 PORCINE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 15 BOVINE SKIN GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 16 BOVINE BONE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 17 FISH & POULTRY GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 TABLE 18 OTHER ANIMAL SOURCES GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 TABLE 19 PLANT-SOURCED GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 5.13 PRICING ANALYSIS 72 5.13.1 AVERAGE SELLING PRICE TREND ANALYSIS 72 TABLE 20 BOVINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 21 PORCINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 22 POULTRY: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 23 MARINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 24 PLANT SOURCES: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 74 TABLE 25 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY MARKET PLAYERS, BY SOURCE, 2022 (USD/TON) 74 5.13.2 KEY STAKEHOLDERS IN BUYING PROCESS 74 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLLAGEN AND GELATIN PRODUCTS 74 5.13.3 BUYING CRITERIA 75 FIGURE 29 KEY BUYING CRITERIA FOR END USERS 75 6 COLLAGEN AND GELATIN MARKET, BY SOURCE 76 6.1 INTRODUCTION 77 TABLE 26 COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77 TABLE 27 GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77 6.2 BOVINE COLLAGEN AND GELATIN SOURCES 78 6.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET 78 TABLE 28 BOVINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 78 TABLE 29 NORTH AMERICA: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79 TABLE 30 EUROPE: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79 TABLE 31 ASIA PACIFIC: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 80 TABLE 32 BOVINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 80 TABLE 33 NORTH AMERICA: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 34 EUROPE: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 35 ASIA PACIFIC: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 82 6.3 PORCINE COLLAGEN AND GELATIN SOURCES 82 6.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND 82 TABLE 36 PORCINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 83 TABLE 37 NORTH AMERICA: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 38 EUROPE: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 39 ASIA PACIFIC: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 40 PORCINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 85 TABLE 41 NORTH AMERICA: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 42 EUROPE: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 43 ASIA PACIFIC: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86 6.4 OTHER COLLAGEN AND GELATIN SOURCES 87 TABLE 44 OTHER SOURCES: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 88 TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 88 TABLE 46 EUROPE: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 47 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 48 OTHER SOURCES: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 90 TABLE 49 NORTH AMERICA: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 90 TABLE 50 EUROPE: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91 TABLE 51 ASIA PACIFIC: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91 7 COLLAGEN MARKET, BY APPLICATION 92 7.1 INTRODUCTION 93 TABLE 52 COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93 7.2 ORTHOPEDIC 93 7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET 93 TABLE 53 ORTHOPEDIC: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 94 TABLE 54 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 55 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95 TABLE 56 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95 7.3 WOUND CARE 96 7.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION 96 TABLE 57 WOUND CARE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 96 TABLE 58 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97 TABLE 59 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97 TABLE 60 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 98 7.4 DENTAL 98 7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET 98 TABLE 61 DENTAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 99 TABLE 62 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99 TABLE 63 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 64 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 7.5 SURGICAL 101 7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS 101 TABLE 65 SURGICAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 101 TABLE 66 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102 TABLE 67 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102 TABLE 68 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 103 7.6 CARDIOVASCULAR 103 7.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH 103 TABLE 69 CARDIOVASCULAR: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 104 TABLE 70 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 71 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105 TABLE 72 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105 7.7 OTHER APPLICATIONS 105 TABLE 73 OTHER APPLICATIONS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 106 TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 106 TABLE 75 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 76 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 8 GELATIN MARKET, BY APPLICATION 108 8.1 INTRODUCTION 109 TABLE 77 GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109 8.2 ORTHOPEDIC 109 8.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET 109 TABLE 78 ORTHOPEDIC: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 110 TABLE 79 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 110 TABLE 80 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111 TABLE 81 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111 8.3 WOUND CARE 112 8.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET 112 TABLE 82 WOUND CARE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 112 TABLE 83 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 84 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 85 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114 8.4 OTHER APPLICATIONS 114 TABLE 86 OTHER APPLICATIONS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 114 TABLE 87 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115 TABLE 88 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115 TABLE 89 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116 9 COLLAGEN AND GELATIN MARKET, BY END USER 117 9.1 INTRODUCTION 118 TABLE 90 COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 118 TABLE 91 GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 118 9.2 HOSPITALS 119 9.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS 119 TABLE 92 HOSPITALS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 120 TABLE 93 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 120 TABLE 94 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121 TABLE 95 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121 TABLE 96 HOSPITALS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 122 TABLE 97 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 122 TABLE 98 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123 TABLE 99 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123 9.3 SURGICAL CENTERS 123 9.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS 123 TABLE 100 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 124 TABLE 101 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125 TABLE 102 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125 TABLE 103 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 126 TABLE 104 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 126 TABLE 105 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127 TABLE 106 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127 TABLE 107 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 128 10 COLLAGEN AND GELATIN MARKET, BY REGION 129 10.1 INTRODUCTION 130 TABLE 108 COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 130 TABLE 109 GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 130 10.2 NORTH AMERICA 131 FIGURE 30 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT 132 TABLE 110 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133 TABLE 111 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 133 TABLE 112 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134 TABLE 113 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 134 FIGURE 31 NORTH AMERICA: GELATIN MARKET SNAPSHOT 135 TABLE 114 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136 TABLE 115 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 136 TABLE 116 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136 TABLE 117 NORTH AMERICA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 137 10.2.1 US 137 10.2.1.1 Increasing incidence of periodontitis and burn injuries to drive market 137 TABLE 118 US: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 138 TABLE 119 US: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138 TABLE 120 US: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 138 TABLE 121 US: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 139 TABLE 122 US: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139 TABLE 123 US: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 139 10.2.2 CANADA 140 10.2.2.1 Growing geriatric population and volume of surgeries to boost collagen and gelatin demand 140 TABLE 124 CANADA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 140 TABLE 125 CANADA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141 TABLE 126 CANADA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 141 TABLE 127 CANADA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 141 TABLE 128 CANADA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142 TABLE 129 CANADA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 142 10.2.3 RECESSION IMPACT ON MARKET IN NORTH AMERICA 142 10.3 EUROPE 143 TABLE 130 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143 TABLE 131 EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 143 TABLE 132 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144 TABLE 133 EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 144 TABLE 134 EUROPE: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145 TABLE 135 EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 145 TABLE 136 EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145 TABLE 137 EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 146 10.3.1 GERMANY 146 10.3.1.1 Increase in healthcare expenditure to boost adoption of collagen and gelatin products 146 TABLE 138 GERMANY: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 147 TABLE 139 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147 TABLE 140 GERMANY: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 147 TABLE 141 GERMANY: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 148 TABLE 142 GERMANY: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148 TABLE 143 GERMANY: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 148 10.3.2 UK 149 10.3.2.1 High risk of pressure ulcers in diabetic patients to drive market 149 TABLE 144 UK: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 149 TABLE 145 UK: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150 TABLE 146 UK: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 150 TABLE 147 UK: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 151 TABLE 148 UK: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 151 TABLE 149 UK: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 151 10.3.3 FRANCE 152 10.3.3.1 Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors 152 TABLE 150 FRANCE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 152 TABLE 151 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153 TABLE 152 FRANCE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 153 TABLE 153 FRANCE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 154 TABLE 154 FRANCE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154 TABLE 155 FRANCE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 154 10.3.4 REST OF EUROPE 155 TABLE 156 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 155 TABLE 157 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156 TABLE 158 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 156 TABLE 159 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 156 TABLE 160 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157 TABLE 161 REST OF EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 157 10.3.5 RECESSION IMPACT ON MARKET IN EUROPE 157 10.4 ASIA PACIFIC 158 FIGURE 32 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT 159 TABLE 162 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160 TABLE 163 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 160 TABLE 164 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161 TABLE 165 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 161 FIGURE 33 ASIA PACIFIC: GELATIN MARKET SNAPSHOT 162 TABLE 166 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163 TABLE 167 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 163 TABLE 168 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163 TABLE 169 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 164 10.4.1 JAPAN 164 10.4.1.1 Rising geriatric population to support market growth 164 TABLE 170 JAPAN: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 165 TABLE 171 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165 TABLE 172 JAPAN: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 165 TABLE 173 JAPAN: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 166 TABLE 174 JAPAN: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166 TABLE 175 JAPAN: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 166 10.4.2 CHINA 167 10.4.2.1 Significant elderly population with diabetes to push demand for collagen and gelatin products 167 TABLE 176 CHINA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 167 TABLE 177 CHINA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168 TABLE 178 CHINA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 168 TABLE 179 CHINA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 168 TABLE 180 CHINA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169 TABLE 181 CHINA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 169 10.4.3 INDIA 169 10.4.3.1 Increasing healthcare spending by government to stimulate market growth 169 TABLE 182 INDIA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 170 TABLE 183 INDIA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171 TABLE 184 INDIA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 171 TABLE 185 INDIA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 172 TABLE 186 INDIA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172 TABLE 187 INDIA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 172 10.4.4 REST OF ASIA PACIFIC 173 TABLE 188 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 173 TABLE 189 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173 TABLE 190 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 174 TABLE 191 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 174 TABLE 192 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174 TABLE 193 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 175 10.4.5 RECESSION IMPACT ON MARKET IN ASIA PACIFIC 175 10.5 REST OF THE WORLD (ROW) 175 TABLE 194 ROW: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 176 TABLE 195 ROW: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 176 TABLE 196 ROW: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177 TABLE 197 ROW: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 177 TABLE 198 ROW: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 177 TABLE 199 ROW: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178 TABLE 200 ROW: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 178 10.5.1 LATIN AMERICA 178 10.5.1.1 Increasing number of diabetic patients to rise demand for collagen and gelatin products 178 TABLE 201 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 179 TABLE 202 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179 TABLE 203 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 180 10.5.2 RECESSION IMPACT ON MARKET IN LATIN AMERICA 180 10.5.3 MIDDLE EAST & AFRICA 180 10.5.3.1 Growing focus on healthcare infrastructure improvement to drive market 180 TABLE 204 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 181 TABLE 205 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 181 10.5.4 RECESSION IMPACT ON MARKET IN MIDDLE EAST & AFRICA 182 11 COMPETITIVE LANDSCAPE 183 11.1 INTRODUCTION 183 11.2 STRATEGIES ADOPTED BY KEY PLAYERS 183 FIGURE 34 COLLAGEN AND GELATIN MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 183 11.3 REVENUE SHARE ANALYSIS 184 FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 184 11.4 MARKET SHARE ANALYSIS 184 FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 185 TABLE 206 COLLAGEN AND GELATIN MARKET: DEGREE OF COMPETITION 185 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 186 FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 187 11.5.1 STARS 188 11.5.2 EMERGING LEADERS 188 11.5.3 PERVASIVE PLAYERS 188 11.5.4 PARTICIPANTS 188 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 189 11.6.1 PRODUCT FOOTPRINT OF 25 COMPANIES 189 TABLE 207 COLLAGEN AND GELATIN MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 189 11.6.2 REGIONAL FOOTPRINT OF 25 COMPANIES 190 TABLE 208 COLLAGEN AND GELATIN MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 190 11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES 191 FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 191 11.7.1 PROGRESSIVE COMPANIES 192 11.7.2 STARTING BLOCKS 192 11.7.3 RESPONSIVE COMPANIES 192 11.7.4 DYNAMIC COMPANIES 192 11.8 COMPETITIVE BENCHMARKING OF START-UP/SMES 192 TABLE 209 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF KEY START-UPS/SMES 192 TABLE 210 COLLAGEN AND GELATIN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 193 11.9 COMPETITIVE SCENARIOS AND TRENDS 194 11.9.1 PRODUCT LAUNCHES 194 TABLE 211 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023 194 11.9.2 DEALS 194 TABLE 212 COLLAGEN AND GELATIN MARKET: DEALS, JANUARY 2020–APRIL 2023 194 12 COMPANY PROFILES 195 12.1 KEY MARKET PLAYERS 195 (Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 INTEGRA LIFESCIENCES 195 TABLE 213 INTEGRA LIFESCIENCES: COMPANY OVERVIEW 195 FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT 196 12.1.2 DSM 199 TABLE 214 ROYAL DSM: COMPANY OVERVIEW 199 FIGURE 40 DSM: COMPANY SNAPSHOT 200 12.1.3 NITTA GELATIN INC. 202 TABLE 215 NITTA GELATIN INC.: COMPANY OVERVIEW 202 FIGURE 41 NITTA GELATIN INC.: COMPANY SNAPSHOT 202 12.1.4 COLLPLANT BIOTECHNOLOGIES LTD. 204 TABLE 216 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW 204 FIGURE 42 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT 204 12.1.5 COLLAGEN SOLUTIONS PLC 207 TABLE 217 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW 207 12.1.6 REGENITY 209 TABLE 218 REGENITY: COMPANY OVERVIEW 209 12.1.7 SYMATESE 211 TABLE 219 SYMATESE: COMPANY OVERVIEW 211 12.1.8 GELITA AG 212 TABLE 220 GELITA AG: COMPANY OVERVIEW 212 TABLE 221 GELITA AG: DEALS 213 12.1.9 TESSENDERLO GROUP (BU PB LINER) 214 TABLE 222 TESSENDERLO GROUP (BU PB LINER): COMPANY OVERVIEW 214 FIGURE 43 TESSENDERLO GROUP (BU PB LINER): COMPANY SNAPSHOT 215 TABLE 223 TESSENDERLO GROUP: DEALS 216 12.1.10 SMITH & NEPHEW PLC 217 TABLE 224 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 217 FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 218 12.1.11 ZIMVIE INC. 220 TABLE 225 ZIMVIE INC.: COMPANY OVERVIEW 220 12.1.12 JELLAGEN 221 TABLE 226 JELLAGEN: COMPANY OVERVIEW 221 TABLE 227 JELLAGEN: PRODUCT OFFERINGS 221 12.2 OTHER PLAYERS 222 12.2.1 ADVANCED BIOMATRIX 222 12.2.2 MATRICEL GMBH 223 12.2.3 ROUSSELOT 223 12.2.4 WEISHARDT 224 12.2.5 XIAMEN HYFINE GELATIN CO., LTD. 225 12.2.6 GEISTLICH PHARMA AG 226 12.2.7 SYNERHEAL PHARMACEUTICALS 227 12.2.8 BIOREGEN TECHNOLOGIES 228 12.2.9 MERIL LIFE SCIENCES PVT. LTD. 229 12.2.10 MEDSKIN SUWELACK 230 12.2.11 COLOGENESIS HEALTHCARE PVT LTD 231 12.2.12 DERMARITE INDUSTRIES, LLC 232 12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED 233 *Details on Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 234 13.1 DISCUSSION GUIDE 234 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 238 13.3 CUSTOMIZATION OPTIONS 240 13.4 RELATED REPORTS 240 13.5 AUTHOR DETAILS 241
SummaryThe global collagen and gelatin market size is projected to reach USD 1.6 billion by 2028 from USD 1.2 billion in 2023, at a CAGR of 6.5% during the forecast period. Factors such as increased adoption of collagen and gelatin in wound care applications coupled with increased funding for collagen and gelatin research is driving the market growth. Increased number of cardiovascular surgeries is further likely to have positive impact on the market growth/ Table of Contents1 INTRODUCTION 291.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.2.1 INCLUSIONS AND EXCLUSIONS 29 1.3 MARKET SCOPE 30 1.3.1 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 31 1.5 LIMITATIONS 31 1.6 STAKEHOLDERS 31 1.7 SUMMARY OF CHANGES 31 1.7.1 RECESSION IMPACT 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 FIGURE 1 COLLAGEN AND GELATIN MARKET: RESEARCH DESIGN 33 2.1.1 SECONDARY DATA 34 2.1.2 PRIMARY DATA 35 FIGURE 2 COLLAGEN AND GELATIN MARKET: BREAKDOWN OF PRIMARIES 35 2.2 MARKET SIZE ESTIMATION 36 FIGURE 3 COLLAGEN AND GELATIN MARKET SIZE ESTIMATION, 2022 36 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 37 FIGURE 5 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES: REVENUE SHARE ANALYSIS, 2022 37 2.2.1 INSIGHTS FROM PRIMARIES 39 FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 39 2.2.2 SEGMENTAL ASSESSMENT (BY SOURCE, APPLICATION, AND END USER): TOP-DOWN APPROACH 39 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 39 2.3 GROWTH RATE ASSUMPTIONS 40 FIGURE 8 COLLAGEN AND GELATIN MARKET: CAGR PROJECTIONS, 2023–2028 41 FIGURE 9 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 41 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 42 FIGURE 10 DATA TRIANGULATION METHODOLOGY 42 2.5 STUDY ASSUMPTIONS 43 2.6 RISK ANALYSIS 43 2.7 IMPACT OF RECESSION ON COLLAGEN AND GELATIN MARKET 43 TABLE 1 GLOBAL INFLATION RATE, 2021–2028 (%) 44 TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 44 TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 44 3 EXECUTIVE SUMMARY 45 FIGURE 11 COLLAGEN AND GELATIN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 45 FIGURE 12 COLLAGEN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 13 GELATIN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 14 COLLAGEN AND GELATIN MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47 FIGURE 15 REGIONAL SNAPSHOT OF COLLAGEN AND GELATIN MARKET 48 4 PREMIUM INSIGHTS 49 4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 49 FIGURE 16 INCREASED PREVALENCE OF DIABETES AND CANCER TO DRIVE MARKET 49 4.2 COLLAGEN AND GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2022 50 FIGURE 17 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN AND GELATIN MARKET, BY SOURCE AND COUNTRY, RESPECTIVELY, IN 2022 50 4.3 COLLAGEN AND GELATIN MARKET SHARE, BY SOURCE, 2023 VS. 2028 51 FIGURE 18 BOVINE SEGMENT TO DOMINATE MARKET IN 2028 51 4.4 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2022 51 FIGURE 19 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2022 51 4.5 COLLAGEN AND GELATIN MARKET GROWTH OPPORTUNITIES, BY COUNTRY, 2023–2028 52 FIGURE 20 JAPAN TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2023 TO 2028 52 FIGURE 21 CHINA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET DURING FORECAST PERIOD 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 TABLE 4 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS 55 5.2.1 DRIVERS 55 5.2.1.1 Increasing prevalence of diabetes & chronic wounds and cancer 55 5.2.1.2 Rising investments and funding in R&D of collagen and gelatin products 56 5.2.1.3 Growing number of surgical procedures 56 TABLE 5 NUMBER OF SURGERIES PERFORMED IN US, 2022–2023 57 5.2.2 RESTRAINTS 57 5.2.2.1 Availability of alternative biomaterials to collagen and gelatin 57 5.2.3 OPPORTUNITIES 58 5.2.3.1 Enforcement of 21st Century Cures Act 58 5.2.4 CHALLENGES 58 5.2.4.1 Lack of advanced manufacturing and marketing technologies 58 5.3 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 59 FIGURE 23 INCREASED USE OF COLLAGEN AND GELATIN PRODUCTS IN WOUND CARE AND SURGICAL PROCEDURES IS LIKELY TO HAVE POSITIVE IMPACT ON THE GROWTH OF THE MARKET 59 5.4 VALUE CHAIN ANALYSIS 59 FIGURE 24 COLLAGEN AND GELATIN MARKET: VALUE CHAIN ANALYSIS 60 5.5 SUPPLY CHAIN 60 FIGURE 25 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET 61 5.6 COLLAGEN AND GELATIN MARKET: ECOSYSTEM ANALYSIS 62 5.7 TECHNOLOGY ANALYSIS 62 5.8 PORTER’S FIVE FORCES ANALYSIS 63 TABLE 6 COLLAGEN AND GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS 63 5.8.1 THREAT OF NEW ENTRANTS 63 5.8.2 THREAT OF SUBSTITUTES 63 5.8.3 BARGAINING POWER OF SUPPLIERS 63 5.8.4 BARGAINING POWER OF BUYERS 64 5.8.5 INTENSITY OF COMPETITIVE RIVALRY 64 5.9 REGULATORY ANALYSIS 64 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 5.10 PATENT ANALYSIS 67 FIGURE 26 PATENTS GRANTED FOR COLLAGEN MARKET, JUNE 2013–JUNE 2023 67 5.10.1 LIST OF MAJOR PATENTS 67 FIGURE 27 PATENTS GRANTED FOR GELATIN MARKET, JUNE 2013–JUNE 2023 69 5.11 KEY CONFERENCES AND EVENTS, 2023–2024 70 TABLE 12 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 70 5.12 PRICING ANALYSIS 70 5.12.1 AVERAGE SELLING PRICE TREND ANALYSIS 70 TABLE 13 GELATIN MARKET: AVERAGE SELLING PRICE, BY SOURCE AND REGION, 2022–2023 (USD/KG) 71 TABLE 14 PORCINE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 15 BOVINE SKIN GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 16 BOVINE BONE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71 TABLE 17 FISH & POULTRY GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 TABLE 18 OTHER ANIMAL SOURCES GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 TABLE 19 PLANT-SOURCED GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72 5.13 PRICING ANALYSIS 72 5.13.1 AVERAGE SELLING PRICE TREND ANALYSIS 72 TABLE 20 BOVINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 21 PORCINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 22 POULTRY: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 23 MARINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73 TABLE 24 PLANT SOURCES: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 74 TABLE 25 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY MARKET PLAYERS, BY SOURCE, 2022 (USD/TON) 74 5.13.2 KEY STAKEHOLDERS IN BUYING PROCESS 74 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLLAGEN AND GELATIN PRODUCTS 74 5.13.3 BUYING CRITERIA 75 FIGURE 29 KEY BUYING CRITERIA FOR END USERS 75 6 COLLAGEN AND GELATIN MARKET, BY SOURCE 76 6.1 INTRODUCTION 77 TABLE 26 COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77 TABLE 27 GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77 6.2 BOVINE COLLAGEN AND GELATIN SOURCES 78 6.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET 78 TABLE 28 BOVINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 78 TABLE 29 NORTH AMERICA: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79 TABLE 30 EUROPE: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79 TABLE 31 ASIA PACIFIC: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 80 TABLE 32 BOVINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 80 TABLE 33 NORTH AMERICA: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 34 EUROPE: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 35 ASIA PACIFIC: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 82 6.3 PORCINE COLLAGEN AND GELATIN SOURCES 82 6.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND 82 TABLE 36 PORCINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 83 TABLE 37 NORTH AMERICA: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 38 EUROPE: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 39 ASIA PACIFIC: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 40 PORCINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 85 TABLE 41 NORTH AMERICA: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 42 EUROPE: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 43 ASIA PACIFIC: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86 6.4 OTHER COLLAGEN AND GELATIN SOURCES 87 TABLE 44 OTHER SOURCES: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 88 TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 88 TABLE 46 EUROPE: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 47 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 48 OTHER SOURCES: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 90 TABLE 49 NORTH AMERICA: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 90 TABLE 50 EUROPE: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91 TABLE 51 ASIA PACIFIC: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91 7 COLLAGEN MARKET, BY APPLICATION 92 7.1 INTRODUCTION 93 TABLE 52 COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93 7.2 ORTHOPEDIC 93 7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET 93 TABLE 53 ORTHOPEDIC: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 94 TABLE 54 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 55 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95 TABLE 56 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95 7.3 WOUND CARE 96 7.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION 96 TABLE 57 WOUND CARE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 96 TABLE 58 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97 TABLE 59 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97 TABLE 60 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 98 7.4 DENTAL 98 7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET 98 TABLE 61 DENTAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 99 TABLE 62 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99 TABLE 63 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 64 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 7.5 SURGICAL 101 7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS 101 TABLE 65 SURGICAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 101 TABLE 66 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102 TABLE 67 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102 TABLE 68 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 103 7.6 CARDIOVASCULAR 103 7.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH 103 TABLE 69 CARDIOVASCULAR: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 104 TABLE 70 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 71 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105 TABLE 72 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105 7.7 OTHER APPLICATIONS 105 TABLE 73 OTHER APPLICATIONS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 106 TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 106 TABLE 75 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 76 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107 8 GELATIN MARKET, BY APPLICATION 108 8.1 INTRODUCTION 109 TABLE 77 GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109 8.2 ORTHOPEDIC 109 8.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET 109 TABLE 78 ORTHOPEDIC: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 110 TABLE 79 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 110 TABLE 80 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111 TABLE 81 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111 8.3 WOUND CARE 112 8.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET 112 TABLE 82 WOUND CARE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 112 TABLE 83 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 84 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 85 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114 8.4 OTHER APPLICATIONS 114 TABLE 86 OTHER APPLICATIONS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 114 TABLE 87 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115 TABLE 88 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115 TABLE 89 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116 9 COLLAGEN AND GELATIN MARKET, BY END USER 117 9.1 INTRODUCTION 118 TABLE 90 COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 118 TABLE 91 GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 118 9.2 HOSPITALS 119 9.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS 119 TABLE 92 HOSPITALS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 120 TABLE 93 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 120 TABLE 94 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121 TABLE 95 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121 TABLE 96 HOSPITALS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 122 TABLE 97 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 122 TABLE 98 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123 TABLE 99 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123 9.3 SURGICAL CENTERS 123 9.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS 123 TABLE 100 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 124 TABLE 101 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125 TABLE 102 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125 TABLE 103 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 126 TABLE 104 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 126 TABLE 105 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127 TABLE 106 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127 TABLE 107 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 128 10 COLLAGEN AND GELATIN MARKET, BY REGION 129 10.1 INTRODUCTION 130 TABLE 108 COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 130 TABLE 109 GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 130 10.2 NORTH AMERICA 131 FIGURE 30 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT 132 TABLE 110 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133 TABLE 111 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 133 TABLE 112 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134 TABLE 113 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 134 FIGURE 31 NORTH AMERICA: GELATIN MARKET SNAPSHOT 135 TABLE 114 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136 TABLE 115 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 136 TABLE 116 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136 TABLE 117 NORTH AMERICA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 137 10.2.1 US 137 10.2.1.1 Increasing incidence of periodontitis and burn injuries to drive market 137 TABLE 118 US: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 138 TABLE 119 US: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138 TABLE 120 US: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 138 TABLE 121 US: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 139 TABLE 122 US: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139 TABLE 123 US: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 139 10.2.2 CANADA 140 10.2.2.1 Growing geriatric population and volume of surgeries to boost collagen and gelatin demand 140 TABLE 124 CANADA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 140 TABLE 125 CANADA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141 TABLE 126 CANADA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 141 TABLE 127 CANADA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 141 TABLE 128 CANADA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142 TABLE 129 CANADA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 142 10.2.3 RECESSION IMPACT ON MARKET IN NORTH AMERICA 142 10.3 EUROPE 143 TABLE 130 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143 TABLE 131 EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 143 TABLE 132 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144 TABLE 133 EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 144 TABLE 134 EUROPE: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145 TABLE 135 EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 145 TABLE 136 EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145 TABLE 137 EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 146 10.3.1 GERMANY 146 10.3.1.1 Increase in healthcare expenditure to boost adoption of collagen and gelatin products 146 TABLE 138 GERMANY: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 147 TABLE 139 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147 TABLE 140 GERMANY: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 147 TABLE 141 GERMANY: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 148 TABLE 142 GERMANY: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148 TABLE 143 GERMANY: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 148 10.3.2 UK 149 10.3.2.1 High risk of pressure ulcers in diabetic patients to drive market 149 TABLE 144 UK: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 149 TABLE 145 UK: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150 TABLE 146 UK: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 150 TABLE 147 UK: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 151 TABLE 148 UK: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 151 TABLE 149 UK: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 151 10.3.3 FRANCE 152 10.3.3.1 Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors 152 TABLE 150 FRANCE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 152 TABLE 151 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153 TABLE 152 FRANCE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 153 TABLE 153 FRANCE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 154 TABLE 154 FRANCE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154 TABLE 155 FRANCE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 154 10.3.4 REST OF EUROPE 155 TABLE 156 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 155 TABLE 157 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156 TABLE 158 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 156 TABLE 159 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 156 TABLE 160 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157 TABLE 161 REST OF EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 157 10.3.5 RECESSION IMPACT ON MARKET IN EUROPE 157 10.4 ASIA PACIFIC 158 FIGURE 32 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT 159 TABLE 162 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160 TABLE 163 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 160 TABLE 164 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161 TABLE 165 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 161 FIGURE 33 ASIA PACIFIC: GELATIN MARKET SNAPSHOT 162 TABLE 166 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163 TABLE 167 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 163 TABLE 168 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163 TABLE 169 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 164 10.4.1 JAPAN 164 10.4.1.1 Rising geriatric population to support market growth 164 TABLE 170 JAPAN: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 165 TABLE 171 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165 TABLE 172 JAPAN: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 165 TABLE 173 JAPAN: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 166 TABLE 174 JAPAN: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166 TABLE 175 JAPAN: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 166 10.4.2 CHINA 167 10.4.2.1 Significant elderly population with diabetes to push demand for collagen and gelatin products 167 TABLE 176 CHINA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 167 TABLE 177 CHINA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168 TABLE 178 CHINA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 168 TABLE 179 CHINA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 168 TABLE 180 CHINA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169 TABLE 181 CHINA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 169 10.4.3 INDIA 169 10.4.3.1 Increasing healthcare spending by government to stimulate market growth 169 TABLE 182 INDIA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 170 TABLE 183 INDIA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171 TABLE 184 INDIA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 171 TABLE 185 INDIA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 172 TABLE 186 INDIA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172 TABLE 187 INDIA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 172 10.4.4 REST OF ASIA PACIFIC 173 TABLE 188 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 173 TABLE 189 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173 TABLE 190 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 174 TABLE 191 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 174 TABLE 192 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174 TABLE 193 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 175 10.4.5 RECESSION IMPACT ON MARKET IN ASIA PACIFIC 175 10.5 REST OF THE WORLD (ROW) 175 TABLE 194 ROW: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 176 TABLE 195 ROW: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 176 TABLE 196 ROW: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177 TABLE 197 ROW: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 177 TABLE 198 ROW: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 177 TABLE 199 ROW: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178 TABLE 200 ROW: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 178 10.5.1 LATIN AMERICA 178 10.5.1.1 Increasing number of diabetic patients to rise demand for collagen and gelatin products 178 TABLE 201 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 179 TABLE 202 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179 TABLE 203 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 180 10.5.2 RECESSION IMPACT ON MARKET IN LATIN AMERICA 180 10.5.3 MIDDLE EAST & AFRICA 180 10.5.3.1 Growing focus on healthcare infrastructure improvement to drive market 180 TABLE 204 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 181 TABLE 205 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 181 10.5.4 RECESSION IMPACT ON MARKET IN MIDDLE EAST & AFRICA 182 11 COMPETITIVE LANDSCAPE 183 11.1 INTRODUCTION 183 11.2 STRATEGIES ADOPTED BY KEY PLAYERS 183 FIGURE 34 COLLAGEN AND GELATIN MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 183 11.3 REVENUE SHARE ANALYSIS 184 FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 184 11.4 MARKET SHARE ANALYSIS 184 FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 185 TABLE 206 COLLAGEN AND GELATIN MARKET: DEGREE OF COMPETITION 185 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 186 FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 187 11.5.1 STARS 188 11.5.2 EMERGING LEADERS 188 11.5.3 PERVASIVE PLAYERS 188 11.5.4 PARTICIPANTS 188 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 189 11.6.1 PRODUCT FOOTPRINT OF 25 COMPANIES 189 TABLE 207 COLLAGEN AND GELATIN MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 189 11.6.2 REGIONAL FOOTPRINT OF 25 COMPANIES 190 TABLE 208 COLLAGEN AND GELATIN MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 190 11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES 191 FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 191 11.7.1 PROGRESSIVE COMPANIES 192 11.7.2 STARTING BLOCKS 192 11.7.3 RESPONSIVE COMPANIES 192 11.7.4 DYNAMIC COMPANIES 192 11.8 COMPETITIVE BENCHMARKING OF START-UP/SMES 192 TABLE 209 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF KEY START-UPS/SMES 192 TABLE 210 COLLAGEN AND GELATIN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 193 11.9 COMPETITIVE SCENARIOS AND TRENDS 194 11.9.1 PRODUCT LAUNCHES 194 TABLE 211 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023 194 11.9.2 DEALS 194 TABLE 212 COLLAGEN AND GELATIN MARKET: DEALS, JANUARY 2020–APRIL 2023 194 12 COMPANY PROFILES 195 12.1 KEY MARKET PLAYERS 195 (Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 INTEGRA LIFESCIENCES 195 TABLE 213 INTEGRA LIFESCIENCES: COMPANY OVERVIEW 195 FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT 196 12.1.2 DSM 199 TABLE 214 ROYAL DSM: COMPANY OVERVIEW 199 FIGURE 40 DSM: COMPANY SNAPSHOT 200 12.1.3 NITTA GELATIN INC. 202 TABLE 215 NITTA GELATIN INC.: COMPANY OVERVIEW 202 FIGURE 41 NITTA GELATIN INC.: COMPANY SNAPSHOT 202 12.1.4 COLLPLANT BIOTECHNOLOGIES LTD. 204 TABLE 216 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW 204 FIGURE 42 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT 204 12.1.5 COLLAGEN SOLUTIONS PLC 207 TABLE 217 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW 207 12.1.6 REGENITY 209 TABLE 218 REGENITY: COMPANY OVERVIEW 209 12.1.7 SYMATESE 211 TABLE 219 SYMATESE: COMPANY OVERVIEW 211 12.1.8 GELITA AG 212 TABLE 220 GELITA AG: COMPANY OVERVIEW 212 TABLE 221 GELITA AG: DEALS 213 12.1.9 TESSENDERLO GROUP (BU PB LINER) 214 TABLE 222 TESSENDERLO GROUP (BU PB LINER): COMPANY OVERVIEW 214 FIGURE 43 TESSENDERLO GROUP (BU PB LINER): COMPANY SNAPSHOT 215 TABLE 223 TESSENDERLO GROUP: DEALS 216 12.1.10 SMITH & NEPHEW PLC 217 TABLE 224 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 217 FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 218 12.1.11 ZIMVIE INC. 220 TABLE 225 ZIMVIE INC.: COMPANY OVERVIEW 220 12.1.12 JELLAGEN 221 TABLE 226 JELLAGEN: COMPANY OVERVIEW 221 TABLE 227 JELLAGEN: PRODUCT OFFERINGS 221 12.2 OTHER PLAYERS 222 12.2.1 ADVANCED BIOMATRIX 222 12.2.2 MATRICEL GMBH 223 12.2.3 ROUSSELOT 223 12.2.4 WEISHARDT 224 12.2.5 XIAMEN HYFINE GELATIN CO., LTD. 225 12.2.6 GEISTLICH PHARMA AG 226 12.2.7 SYNERHEAL PHARMACEUTICALS 227 12.2.8 BIOREGEN TECHNOLOGIES 228 12.2.9 MERIL LIFE SCIENCES PVT. LTD. 229 12.2.10 MEDSKIN SUWELACK 230 12.2.11 COLOGENESIS HEALTHCARE PVT LTD 231 12.2.12 DERMARITE INDUSTRIES, LLC 232 12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED 233 *Details on Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 234 13.1 DISCUSSION GUIDE 234 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 238 13.3 CUSTOMIZATION OPTIONS 240 13.4 RELATED REPORTS 240 13.5 AUTHOR DETAILS 241
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
MarketsandMarkets社のBiotechnology分野での最新刊レポート
本レポートと同じKEY WORD(gelatin)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |